NCT03267498 2026-01-12
Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC)
University of California, San Francisco
Phase 2 Completed
Clinical Trials
10 trialsNCT02287311 2025-02-24
MABEL
Baylor College of Medicine
Phase 1 Active not recruiting
NCT02538510 2024-11-26
Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery
University of Washington
Phase 1/2 Completed
NCT00834093 2023-06-28
A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma
Dana-Farber Cancer Institute
Phase 2 Completed
NCT00592501 2021-10-26
Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma
Massachusetts General Hospital
Phase 2 Completed
NCT01344356 2020-04-10
Stereotactic Body Radiotherapy for Head and Neck Tumors
Mercy Research
Phase 4 Completed
NCT01621880 2019-01-09
BRAIN
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Completed
NCT02584790 2017-12-08
NBI to Detect Post-RT Mucosal Residual NPC
Pamela Youde Nethersole Eastern Hospital
Phase NA Completed
NCT00815087 2014-03-26
Functional Electrical Stimulation in Irradiated Nasopharyngeal Carcinoma (NPC)
National Taiwan University Hospital
Phase 2 Completed
NCT00700440 2010-03-26
ENCORE
Sun Yat-sen University
Phase 2 Completed